3D Cell Culture Market Surpasses $2.5 Billion: Driving Innovations in Regenerative Medicine

3D cell culture market

The global 3D cell culture market size is estimated to reach USD 2.5 billion by 2028 from USD 1.3 billion in 2023, at a CAGR of 14.6% during the forecast period. Increased focus on development of alternatives to animal testing, rising government support and funding for 3D cell culture market and augmented demand for personalized medicine is propelling the market growth of 3D cell culture market.

Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191072847

Based on the product, the 3D cell culture market is segmented into scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures. Scaffold-based 3D cell cultures accounted for the largest share of this market in 2022. The dominant share of the segment is mainly due to advantages of scaffold-based cell culture such as the availability of attachment points, & support and structural rigidity.

Based on application, the 3D cell culture market is segmented into cancer & stem cell research, drug discovery & toxicology testing, and tissue engineering & regenerative medicine. Cancer & stem cell research accounted for the largest market share of the market in 2022. The increasing prevalence of cancer and growing funding for cancer research from the government and the private sector are some of the major factors favouring the growth of this application segment. 

On the basis of end users, the 3D cell culture market is segmented into pharmaceutical & biotechnology companies, research institutes, the cosmetics industry, and other end users. Pharmaceutical & biotechnology companies accounted for largest share of the 3D cell culture market in 2022. The growing preference for alternative testing models over animal techniques and adoption of 3D cell culture model are the factors driving the growth of this end user segment.

Based on region, the global 3D cell culture market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America had the largest share of the market In 2022. Asia Pacific region is likely to grow at a faster pace during the forecast period of 2023-2028. The factors attributable to the faster growth rate are well-established pharmaceutical & biotechnology companies, increased adoption of 3D cell culture in personalized medicine and rise in fundings by government for 3D cell culture research. Asia Pacific region is anticipated to grow at faster pace.

The 3D cell culture market is consolidated, with a small number of players competing for market shares. Thermo Fisher Scientific. Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), and Avantor Inc. (US) are some of the leading players in this market.

Recent Developments of 3D Cell Culture Industry

In October 2022, Corning launched the Elplasia 12K flask featuring a unique microcavity geometry that enables easy spheroid formation, culture, treatment, assessment, and harvest, with approximately 12,000 spheroids of uniform size and shape per flask, generating 125 times more yield than conventional 96-well spheroid plates.

In March 2021, Thermo Fisher Scientific launched a plasma-like medium, a cell culture medium that mimics the metabolic profile of human plasma, designed to provide researchers with a realistic view of cell growth within the human body.